Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVeracyte Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | $0.30 | $0.36 | $0.33 |
| Q2 2026 | 7 | $0.35 | $0.47 | $0.42 |
| Q3 2026 | 3 | $0.43 | $0.45 | $0.44 |
| Q4 2026 | 3 | $0.46 | $0.47 | $0.47 |
| Q1 2027 | 3 | $0.38 | $0.39 | $0.38 |
| Q2 2027 | 2 | $0.43 | $0.44 | $0.44 |
| Q3 2027 | 2 | $0.44 | $0.46 | $0.45 |
| Q4 2027 | 2 | $0.47 | $0.49 | $0.48 |
| Q1 2028 | 3 | $0.34 | $0.35 | $0.34 |
| Q2 2028 | 6 | $0.42 | $0.43 | $0.43 |
| Q3 2028 | 5 | $0.44 | $0.45 | $0.44 |
| Q4 2028 | 5 | $0.48 | $0.50 | $0.49 |
Veracyte Inc Earnings Date And Information
Veracyte Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.18. The company had revenue of 139.07 M for the quarter and had revenue of 517.15 M for the year. Veracyte Inc has generated $1 earnings per share over the last year ($0.82 diluted earnings per share) and currently has a price-to-earnings ratio of 37.43. Veracyte Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Veracyte Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | N/A | $0.36 | N/A | $130.25 M | $139.07 M |
| 02/26/2026 | Q4 2025 | N/A | $0.52 | N/A | $135.43 M | $140.64 M |
| 11/05/2025 | Q3 2025 | N/A | $0.24 | N/A | $124.97 M | $131.87 M |
| 08/07/2025 | Q2 2025 | N/A | -$0.01 | N/A | $121.04 M | $130.16 M |
| 05/08/2025 | Q1 2025 | N/A | $0.09 | N/A | $111.27 M | $114.47 M |
| 02/27/2025 | Q4 2024 | N/A | $0.07 | N/A | $116.70 M | $118.63 M |
| 11/07/2024 | Q3 2024 | N/A | $0.20 | N/A | $109.82 M | $115.86 M |
| 08/07/2024 | Q2 2024 | N/A | $0.07 | N/A | $100.27 M | $114.43 M |
| 05/08/2024 | Q1 2024 | N/A | -$0.02 | N/A | $93.35 M | $96.84 M |
| 02/29/2024 | Q4 2023 | N/A | -$0.39 | N/A | N/A | $98.20 M |
| 11/08/2023 | Q3 2023 | N/A | -$0.41 | N/A | N/A | $90.11 M |
| 08/09/2023 | Q2 2023 | N/A | -$0.12 | N/A | N/A | $90.32 M |
| 05/05/2023 | Q1 2023 | N/A | -$0.11 | N/A | N/A | $82.42 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.05 | N/A | N/A | $80.30 M |
| 11/03/2022 | Q3 2022 | N/A | -$0.12 | N/A | N/A | $75.59 M |
| 08/03/2022 | Q2 2022 | N/A | -$0.13 | N/A | N/A | $72.86 M |
| 05/03/2022 | Q1 2022 | N/A | -$0.20 | N/A | N/A | $67.78 M |
| 02/28/2022 | Q4 2021 | -$0.14 | -$0.15 | -0.01 | N/A | $67.34 M |
| 11/09/2021 | Q3 2021 | -$0.14 | -$0.20 | -0.06 | N/A | $60.37 M |
| 07/29/2021 | Q2 2021 | -$0.25 | -$0.13 | 0.12 | N/A | $55.11 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Veracyte Inc Earnings: FAQ's
In the previous quarter, Veracyte Inc (:VCYT) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.34 by $0.18.
The conference call for Veracyte Inc's latest earnings report can be listened to online.
The conference call transcript for Veracyte Inc's latest earnings report can be read online.
Veracyte Inc (:VCYT) has a recorded annual revenue of $517.15 M.
Veracyte Inc (:VCYT) has a recorded net income of $66.35 M.Veracyte Inc has generated $0.84 earnings per share over the last four quarters.
Veracyte Inc (:VCYT) has a price-to-earnings ratio of 37.43 and price/earnings-to-growth ratio is 0.24.